Imfinzi (durvalumab) - AstraZeneca
Tecentriq (atezolizumab) - Roche
Opdivo (nivolumab) - Ono Pharma, BMS
Cyramza (ramucirumab) - Eli Lilly
Bavencio (avelumab) - EMD Serono
docetaxel - Generic mfg.
Keytruda (pembrolizumab) - Merck (MSD)
Tarvacin (bavituximab) - Feng Biosci
Tevimbra (tislelizumab) - BeiGene
Tyvyt (sintilimab) - Innovent Biologics
https://www.ispor.org/heor-resources/presentations-database/presentation/intl2024-3897/139005
 
Voon PJ1; Di Maio M2; Coaquira Castro J3; Chaudhary T4; Finn E5; Xu W6; Zhan L3
 
Mar 8, 2024
 
Prev Next